Shares of medical devices company AngioDynamics, Inc. (ANGO) are rising more than 10% Thursday morning on better-than-expected second-quarter results.
The company reported a net loss of $4.3 million, or $0.11 per share in the second quarter compared with net loss of $2.7 million, or $0.07 per share, a year ago.
On an adjusted basis, earnings of $0.01 per share in the quarter beat the average estimate of analysts polled by Thomson Reuters for a loss of $0.02 per share.
Net sales for the second quarter increased 4% year-over-year to $72.8 million. The consensus estimate was for $67.35 million.
"In the second half of the year, we expect ongoing COVID-related headwinds as well as typical third-quarter seasonality, which is contemplated in our full-year guidance. We are excited about the planned launch of our multi-purpose mechanical aspiration thrombectomy device in calendar 2021," said Jim Clemmer, President and Chief Executive Officer of AngioDynamics, Inc.
ANGO, currently at $17.94, touched a new high of $19.52 this morning.
For comments and feedback contact: editorial@rttnews.com
Business News
April 17, 2026 15:29 ET The ongoing conflict in the Middle East continues to raise concerns for policymakers who worry about the impact of the supply shock and high energy prices on the real economy. Producer price data and various survey results on the housing market were the main news from the U.S. this week. In Europe, industrial production data for the euro area gained attention. GDP figures out of China and the policy move by the Singapore central bank were in focus in Asia.